Birch Grove Capital’s CVS Health CVS Stock Holding History

Birch Grove Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34,900	Closed	-$2.63M	–	48
2021 Q1	$2.63M	Buy	+34,900	New	+$2.54M	1.14%	29

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Birch Grove Capital's CVS Position: Q2 2021 in Review

Birch Grove Capital sold out of CVS Health (CVS) in Q2 2021, closing a stake of 34,900 shares — an estimated $2.63M sold.

Birch Grove Capital first reported a position in CVS in Q1 2021 and held it in 1 quarter. The position peaked at $2.63M in Q1 2021. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

Birch Grove Capital reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
Birch Grove Capital sold 34,900 CVS Health shares in Q2 2021, an estimated $2.63M.
Birch Grove Capital first reported a position in CVS Health in Q1 2021 and held it in 1 quarter.
Birch Grove Capital's CVS Health position peaked at $2.63M in Q1 2021.
2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Birch Grove Capital's 13F filing for Q2 2021, filed 16 Aug 2021.